Eintrag weiter verarbeiten
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis.
Gespeichert in:
Zeitschriftentitel: | Acta Biochimica Polonica |
---|---|
Personen und Körperschaften: | , |
In: | Acta Biochimica Polonica, 50, 2003, 1, S. 49-59 |
Format: | E-Article |
Sprache: | Unbestimmt |
veröffentlicht: |
Frontiers Media SA
|
Schlagwörter: |
author_facet |
Kimura, Hideo Esumi, Hiroyasu Kimura, Hideo Esumi, Hiroyasu |
---|---|
author |
Kimura, Hideo Esumi, Hiroyasu |
spellingShingle |
Kimura, Hideo Esumi, Hiroyasu Acta Biochimica Polonica Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. General Biochemistry, Genetics and Molecular Biology |
author_sort |
kimura, hideo |
spelling |
Kimura, Hideo Esumi, Hiroyasu 1734-154X 0001-527X Frontiers Media SA General Biochemistry, Genetics and Molecular Biology http://dx.doi.org/10.18388/abp.2003_3713 <jats:p>Physiologically, angiogenesis is tightly regulated, or otherwise it leads to pathological processes, such as tumors, inflammatory diseases, gynecological diseases and diabetic retinopathy. The vascular endothelial growth factor (VEGF) is a potent and critical inducer of angiogenesis. The VEGF gene expression is regulated by a variety of stimuli. Hypoxia is one of the most potent inducers of the VEGF expression. The hypoxia inducible factor 1 (HIF-1) plays as a key transcription factor in hypoxia-mediated VEGF gene upregulation. Nitric oxide (NO) as well as hypoxia is reported to upregulate the VEGF gene by enhancing HIF-1 activity. The Akt/protein kinase B (PKB) pathway may be involved in NO-mediated HIF-1 activation in limited cell lines. There are some reports of negative effects of NO on HIF-1 and VEGF activity. These conflicting data of NO effects may be attributed mainly to the amount of released NO. Indeed, NO can be a positive or negative modulator of the VEGF gene under the same conditions simply by changing its amounts. The VEGF-mediated angiogenesis requires NO production from activated endothelial NO synthase (eNOS). Activation of eNOS by VEGF involves several pathways including Akt/PKB, Ca(2+)/calmodulin, and protein kinase C. The NO-mediated VEGF expression can be regulated by HIF-1 and heme oxygenase 1 (HO-1) activity, and the VEGF-mediated NO production by eNOS can be also modulated by HIF-1 and HO-1 activity, depending upon the amount of produced NO. These reciprocal relations between NO and VEGF may contribute to regulated angiogenesis in normal tissues.</jats:p> Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochimica Polonica |
doi_str_mv |
10.18388/abp.2003_3713 |
facet_avail |
Online Free |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTgzODgvYWJwLjIwMDNfMzcxMw |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTgzODgvYWJwLjIwMDNfMzcxMw |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
Frontiers Media SA, 2003 |
imprint_str_mv |
Frontiers Media SA, 2003 |
issn |
0001-527X 1734-154X |
issn_str_mv |
0001-527X 1734-154X |
language |
Undetermined |
mega_collection |
Frontiers Media SA (CrossRef) |
match_str |
kimura2003reciprocalregulationbetweennitricoxideandvascularendothelialgrowthfactorinangiogenesis |
publishDateSort |
2003 |
publisher |
Frontiers Media SA |
recordtype |
ai |
record_format |
ai |
series |
Acta Biochimica Polonica |
source_id |
49 |
title |
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_unstemmed |
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_full |
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_fullStr |
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_full_unstemmed |
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_short |
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_sort |
reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
topic |
General Biochemistry, Genetics and Molecular Biology |
url |
http://dx.doi.org/10.18388/abp.2003_3713 |
publishDate |
2003 |
physical |
49-59 |
description |
<jats:p>Physiologically, angiogenesis is tightly regulated, or otherwise it leads to pathological processes, such as tumors, inflammatory diseases, gynecological diseases and diabetic retinopathy. The vascular endothelial growth factor (VEGF) is a potent and critical inducer of angiogenesis. The VEGF gene expression is regulated by a variety of stimuli. Hypoxia is one of the most potent inducers of the VEGF expression. The hypoxia inducible factor 1 (HIF-1) plays as a key transcription factor in hypoxia-mediated VEGF gene upregulation. Nitric oxide (NO) as well as hypoxia is reported to upregulate the VEGF gene by enhancing HIF-1 activity. The Akt/protein kinase B (PKB) pathway may be involved in NO-mediated HIF-1 activation in limited cell lines. There are some reports of negative effects of NO on HIF-1 and VEGF activity. These conflicting data of NO effects may be attributed mainly to the amount of released NO. Indeed, NO can be a positive or negative modulator of the VEGF gene under the same conditions simply by changing its amounts. The VEGF-mediated angiogenesis requires NO production from activated endothelial NO synthase (eNOS). Activation of eNOS by VEGF involves several pathways including Akt/PKB, Ca(2+)/calmodulin, and protein kinase C. The NO-mediated VEGF expression can be regulated by HIF-1 and heme oxygenase 1 (HO-1) activity, and the VEGF-mediated NO production by eNOS can be also modulated by HIF-1 and HO-1 activity, depending upon the amount of produced NO. These reciprocal relations between NO and VEGF may contribute to regulated angiogenesis in normal tissues.</jats:p> |
container_issue |
1 |
container_start_page |
49 |
container_title |
Acta Biochimica Polonica |
container_volume |
50 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792341568536969221 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:21:59.214Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Reciprocal+regulation+between+nitric+oxide+and+vascular+endothelial+growth+factor+in+angiogenesis.&rft.date=2003-03-31&genre=article&issn=0001-527X&volume=50&issue=1&spage=49&epage=59&pages=49-59&jtitle=Acta+Biochimica+Polonica&atitle=Reciprocal+regulation+between+nitric+oxide+and+vascular+endothelial+growth+factor+in+angiogenesis.&aulast=Esumi&aufirst=Hiroyasu&rft_id=info%3Adoi%2F10.18388%2Fabp.2003_3713&rft.language%5B0%5D=und |
SOLR | |
_version_ | 1792341568536969221 |
author | Kimura, Hideo, Esumi, Hiroyasu |
author_facet | Kimura, Hideo, Esumi, Hiroyasu, Kimura, Hideo, Esumi, Hiroyasu |
author_sort | kimura, hideo |
container_issue | 1 |
container_start_page | 49 |
container_title | Acta Biochimica Polonica |
container_volume | 50 |
description | <jats:p>Physiologically, angiogenesis is tightly regulated, or otherwise it leads to pathological processes, such as tumors, inflammatory diseases, gynecological diseases and diabetic retinopathy. The vascular endothelial growth factor (VEGF) is a potent and critical inducer of angiogenesis. The VEGF gene expression is regulated by a variety of stimuli. Hypoxia is one of the most potent inducers of the VEGF expression. The hypoxia inducible factor 1 (HIF-1) plays as a key transcription factor in hypoxia-mediated VEGF gene upregulation. Nitric oxide (NO) as well as hypoxia is reported to upregulate the VEGF gene by enhancing HIF-1 activity. The Akt/protein kinase B (PKB) pathway may be involved in NO-mediated HIF-1 activation in limited cell lines. There are some reports of negative effects of NO on HIF-1 and VEGF activity. These conflicting data of NO effects may be attributed mainly to the amount of released NO. Indeed, NO can be a positive or negative modulator of the VEGF gene under the same conditions simply by changing its amounts. The VEGF-mediated angiogenesis requires NO production from activated endothelial NO synthase (eNOS). Activation of eNOS by VEGF involves several pathways including Akt/PKB, Ca(2+)/calmodulin, and protein kinase C. The NO-mediated VEGF expression can be regulated by HIF-1 and heme oxygenase 1 (HO-1) activity, and the VEGF-mediated NO production by eNOS can be also modulated by HIF-1 and HO-1 activity, depending upon the amount of produced NO. These reciprocal relations between NO and VEGF may contribute to regulated angiogenesis in normal tissues.</jats:p> |
doi_str_mv | 10.18388/abp.2003_3713 |
facet_avail | Online, Free |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTgzODgvYWJwLjIwMDNfMzcxMw |
imprint | Frontiers Media SA, 2003 |
imprint_str_mv | Frontiers Media SA, 2003 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 0001-527X, 1734-154X |
issn_str_mv | 0001-527X, 1734-154X |
language | Undetermined |
last_indexed | 2024-03-01T16:21:59.214Z |
match_str | kimura2003reciprocalregulationbetweennitricoxideandvascularendothelialgrowthfactorinangiogenesis |
mega_collection | Frontiers Media SA (CrossRef) |
physical | 49-59 |
publishDate | 2003 |
publishDateSort | 2003 |
publisher | Frontiers Media SA |
record_format | ai |
recordtype | ai |
series | Acta Biochimica Polonica |
source_id | 49 |
spelling | Kimura, Hideo Esumi, Hiroyasu 1734-154X 0001-527X Frontiers Media SA General Biochemistry, Genetics and Molecular Biology http://dx.doi.org/10.18388/abp.2003_3713 <jats:p>Physiologically, angiogenesis is tightly regulated, or otherwise it leads to pathological processes, such as tumors, inflammatory diseases, gynecological diseases and diabetic retinopathy. The vascular endothelial growth factor (VEGF) is a potent and critical inducer of angiogenesis. The VEGF gene expression is regulated by a variety of stimuli. Hypoxia is one of the most potent inducers of the VEGF expression. The hypoxia inducible factor 1 (HIF-1) plays as a key transcription factor in hypoxia-mediated VEGF gene upregulation. Nitric oxide (NO) as well as hypoxia is reported to upregulate the VEGF gene by enhancing HIF-1 activity. The Akt/protein kinase B (PKB) pathway may be involved in NO-mediated HIF-1 activation in limited cell lines. There are some reports of negative effects of NO on HIF-1 and VEGF activity. These conflicting data of NO effects may be attributed mainly to the amount of released NO. Indeed, NO can be a positive or negative modulator of the VEGF gene under the same conditions simply by changing its amounts. The VEGF-mediated angiogenesis requires NO production from activated endothelial NO synthase (eNOS). Activation of eNOS by VEGF involves several pathways including Akt/PKB, Ca(2+)/calmodulin, and protein kinase C. The NO-mediated VEGF expression can be regulated by HIF-1 and heme oxygenase 1 (HO-1) activity, and the VEGF-mediated NO production by eNOS can be also modulated by HIF-1 and HO-1 activity, depending upon the amount of produced NO. These reciprocal relations between NO and VEGF may contribute to regulated angiogenesis in normal tissues.</jats:p> Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochimica Polonica |
spellingShingle | Kimura, Hideo, Esumi, Hiroyasu, Acta Biochimica Polonica, Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis., General Biochemistry, Genetics and Molecular Biology |
title | Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_full | Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_fullStr | Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_full_unstemmed | Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_short | Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_sort | reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
title_unstemmed | Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. |
topic | General Biochemistry, Genetics and Molecular Biology |
url | http://dx.doi.org/10.18388/abp.2003_3713 |